| Stage | AXON | % of rev | SWBI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $904M | 100.00% | $113M | 100.00% | AXON ×8.03 |
| Gross profit | $546M | 60.42% | $32M | 28.66% | AXON +31.8pp |
| Operating income | $47M | 5.17% | $4M | 3.75% | AXON +1.4pp |
| Pre-tax income | $33M | 3.61% | $4M | 3.57% | 0.0pp |
| Net income | $29M | 3.25% | $3M | 2.30% | AXON +1.0pp |
| Stage | AXON | SWBI | Gap · A − B |
|---|---|---|---|
| Revenue | $904M100.00% | $113M100.00% | AXON ×8.03 |
| Gross profit | 60.42%$546M | 28.66%$32M | AXON +31.8pp |
| Operating income | 5.17%$47M | 3.75%$4M | AXON +1.4pp |
| Pre-tax income | 3.61%$33M | 3.57%$4M | 0.0pp |
| Net income |
| 3.25%$29M |
| 2.30%$3M |
| AXON +1.0pp |
None
No disclosed counterparties: AXON.